• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Hemostatic durability of gelatin sponge particles with tranexiamic acid in Transcatheter Arterial Embolization for Acute Arterial Hemorrhage in a Coagulopathic Condition in a Swine Model

Research Project

Project/Area Number 25861728
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Emergency medicine
Research InstitutionWakayama Medical University

Principal Investigator

YONEMITSU Takafumi  和歌山県立医科大学, 医学部, 助教 (80382331)

Research Collaborator SHIBATA Naoaki  和歌山県立医科大学, 医学部, 学内助教 (60597201)
OGAWA Atsuhiro  和歌山県立医科大学, 医学部, 学内助教
Project Period (FY) 2013-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords外傷 / TAE / 塞栓物質 / 凝固障害 / ゼラチンスポンジ / トラネキサム酸 / 重症外傷 / 外傷ショック / 高度凝固障害
Outline of Final Research Achievements

The aim of this experimental study in a swine model is to strengthen the embolic effect of gelatin sponge as an ordinary embolic agent which even emergency physician can use easily in a coagulopathic condition with adding tranexamic acid.
We assigned eight swines ( 32 kidney injuries ) to traumatic hemorrhage models with or without coagulopathy by intravenous urokinase, and embolise bleeding artery with gelatin sponge alone ( GS ) or geratin sponge plus tranexamic asid (TXA-GS). We evaluated 1) primary hemostasis, 2) rebleeding in 5 min, 10 min, 15min and 30min after primary hemostasis, 3) pathological diagnosis. Consequently, it was suggested that TXA-GS embolization is more effective GS embolization in a coagulopathic condition in a swine model.

Report

(3 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi